Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Karin Frank-Raue

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Procedures

Thyroidectomy

Physiology

Living Beings

Concepts & Ideas

Neoplasm Staging

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Schellhaas Elisabeth; König Charlotte; Frank-Raue Karin; Buhr Heinz-J; Hotz Hubert G
Long-term outcome of "prophylactic therapy" for familial medullary thyroid cancer.
Frank-Raue Karin; Raue Friedhelm
Multiple endocrine neoplasia type 2 (MEN 2).
Meyer Sonja-Kerstin; Zorn Markus; Frank-Raue Karin; Büchler Markus W; Nawroth Peter; Weber Theresia
Clinical impact of two different intraoperative parathyroid hormone assays in primary and renal hyperparathyroidism.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Karin Frank-Raue (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Schellhaas Elisabeth; König Charlotte; Frank-Raue Karin; Buhr Heinz-J; Hotz Hubert G
Long-term outcome of "prophylactic therapy" for familial medullary thyroid cancer.
Surgery 2009;146(5):906-12.
2009: Frank-Raue Karin; Raue Friedhelm
Multiple endocrine neoplasia type 2 (MEN 2).
European journal of cancer (Oxford, England : 1990) 2009;45 Suppl 1():267-73.
2009: Meyer Sonja-Kerstin; Zorn Markus; Frank-Raue Karin; Büchler Markus W; Nawroth Peter; Weber Theresia
Clinical impact of two different intraoperative parathyroid hormone assays in primary and renal hyperparathyroidism.
European journal of endocrinology / European Federation of Endocrine Societies 2009;160(2):275-81.
2009: Raue Friedhelm; Frank-Raue Karin
Genotype-phenotype relationship in multiple endocrine neoplasia type 2. Implications for clinical management.
Hormones (Athens, Greece) 2009;8(1):23-8.
2008: Rus Ramona; Haag Christine; Bumke-Vogt Christiane; Bähr Volker; Mayr Bernhard; Möhlig Matthias; Schulze Egbert; Frank-Raue Karin; Raue Friedhelm; Schöfl Christof
Novel inactivating mutations of the calcium-sensing receptor: the calcimimetic NPS R-568 improves signal transduction of mutant receptors.
The Journal of clinical endocrinology and metabolism 2008;93(12):4797-803.
2008: Milos Ioana N; Frank-Raue Karin; Wohllk Nelson; Maia Ana Luiza; Pusiol Eduardo; Patocs Attila; Robledo Mercedes; Biarnes Josefina; Barontini Marta; Links Thera P; de Groot Jan Willem; Dvorakova Sarka; Peczkowska Mariola; Rybicki Lisa A; Sullivan Maren; Raue Friedhelm; Zosin Ioana; Eng Charis; Neumann Hartmut P H
Age-related neoplastic risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germ line RET Cys634Trp (TGC>TGG) mutation.
Endocrine-related cancer 2008;15(4):1035-41.
2008: Frank-Raue Karin; Machens Andreas; Scheuba Christian; Niederle Bruno; Dralle Henning; Raue Friedhelm;
Difference in development of medullary thyroid carcinoma among carriers of RET mutations in codons 790 and 791.
Clinical endocrinology 2008;69(2):259-63.
2008: Colombo-Benkmann Mario; Li Zhenpeng; Riemann Burkhard; Hengst Karin; Herbst Hermann; Keuser Roger; Gross Ute; Rondot Susanne; Raue Friedhelm; Senninger Norbert; Pützer Brigitte M; Frank-Raue Karin
Characterization of the RET protooncogene transmembrane domain mutation S649L associated with nonaggressive medullary thyroid carcinoma.
European journal of endocrinology / European Federation of Endocrine Societies 2008;158(6):811-6.
2007: Machens Andreas; Schaaf Ludwig; Karges Wolfram; Frank-Raue Karin; Bartsch Detlef K; Rothmund Matthias; Schneyer Ulrich; Goretzki Peter; Raue Friedhelm; Dralle Henning
Age-related penetrance of endocrine tumours in multiple endocrine neoplasia type 1 (MEN1): a multicentre study of 258 gene carriers.
Clinical endocrinology 2007;67(4):613-22.
2007: Frank-Raue Karin; Fabel Michael; Delorme Stefan; Haberkorn Uwe; Raue Friedhelm
Efficacy of imatinib mesylate in advanced medullary thyroid carcinoma.
European journal of endocrinology / European Federation of Endocrine Societies 2007;157(2):215-20.
2007: Raue F; Haag Ch; Frank-Raue K
[Hyperparathyroidism-jaw tumor syndrome. A hereditary form of primary hyperparathyroidism with parathyroid carcinoma]
Deutsche medizinische Wochenschrift (1946) 2007;132(27):1459-62.
2007: Raue Friedhelm; Frank-Raue Karin
Primary hyperparathyroidism--what the nephrologist should know--an update.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;22(3):696-9.
2007: Raue Friedhelm; Frank-Raue Karin
Multiple endocrine neoplasia type 2: 2007 update.
Hormone research 2007;68 Suppl 5():101-4.
2007: Frank-Raue Karin; Rondot Susanne; Schulze Egbert; Raue Friedhelm
Change in the spectrum of RET mutations diagnosed between 1994 and 2006.
Clinical laboratory 2007;53(5-6):273-82.
2006: Raue F; Haag C; Schulze E; Frank-Raue K
The role of the extracellular calcium-sensing receptor in health and disease.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2006;114(8):397-405.
2006: Frank-Raue K; Buhr H; Dralle H; Klar E; Senninger N; Weber T; Rondot S; Höppner W; Raue F
Long-term outcome in 46 gene carriers of hereditary medullary thyroid carcinoma after prophylactic thyroidectomy: impact of individual RET genotype.
European journal of endocrinology / European Federation of Endocrine Societies 2006;155(2):229-36.
2005: Frank-Raue Karin; Rondot Susanne; Hoeppner Wolfgang; Goretzki Peter; Raue Friedhelm; Meng Wieland
Coincidence of multiple endocrine neoplasia types 1 and 2: mutations in the RET protooncogene and MEN1 tumor suppressor gene in a family presenting with recurrent primary hyperparathyroidism.
The Journal of clinical endocrinology and metabolism 2005;90(7):4063-7.
2004: Frank-Raue Karin; Lorenz Angela; Haag Christine; Höppner Wolfgang; Boll Hans-Ullrich; Knorr Dietrich; Hentze Sabine; Raue Friedhelm
Severe form of thyroid hormone resistance in a patient with homozygous/hemizygous mutation of T3 receptor gene.
European journal of endocrinology / European Federation of Endocrine Societies 2004;150(6):819-23.
2003: Machens Andreas; Niccoli-Sire Patricia; Hoegel Josef; Frank-Raue Karin; van Vroonhoven Theo J; Roeher Hans-Dietrich; Wahl Robert A; Lamesch Peter; Raue Friedhelm; Conte-Devolx Bernard; Dralle Henning;
Early malignant progression of hereditary medullary thyroid cancer.
The New England journal of medicine 2003;349(16):1517-25.
2003: Frank-Raue K; Heimbach C; Rondot S; Usadel K-H; Meng W; Varma C; Fuchs-Hammoser R; Höppner W; Schulze E; Raue F
[Hereditary medullary thyroid carcinoma--genotype-phenotype characterization]
Deutsche medizinische Wochenschrift (1946) 2003;128(39):1998-2002.
2003: Frank-Raue K; Schulze E
[Hirsutism]
MMW Fortschritte der Medizin 2003;145(31-32):59-60.
2003: Weber Theresia; Lacroix Jeannine; Wörner Stefan; Weckauf Helgard; Winkler Steffi; Hinz Ulf; Schilling Tobias; Frank-Raue Karin; Klar Ernst; Knebel Doeberitz Mv Magnus von
Detection of hematogenic and lymphogenic tumor cell dissemination in patients with medullary thyroid carcinoma by cytokeratin 20 and preprogastrin-releasing peptide RT-PCR.
International journal of cancer. Journal international du cancer 2003;103(1):126-31.
2001: Weber T; Schilling T; Frank-Raue K; Colombo-Benkmann M; Hinz U; Ziegler R; Klar E
Impact of modified radical neck dissection on biochemical cure in medullary thyroid carcinomas.
Surgery 2001;130(6):1044-9.
1999: Behr T M; Béhé M; Angerstein C; Gratz S; Mach R; Hagemann L; Jenner N; Stiehler M; Frank-Raue K; Raue F; Becker W
Cholecystokinin-B/gastrin receptor binding peptides: preclinical development and evaluation of their diagnostic and therapeutic potential.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10 Suppl):3124s-3138s.
1998: Dralle H; Gimm O; Simon D; Frank-Raue K; Görtz G; Niederle B; Wahl R A; Koch B; Walgenbach S; Hampel R; Ritter M M; Spelsberg F; Heiss A; Hinze R; Höppner W
Prophylactic thyroidectomy in 75 children and adolescents with hereditary medullary thyroid carcinoma: German and Austrian experience.
World journal of surgery 1998;22(7):744-50; discussion 750-1.
1998: Hotz H G; Runkel N S; Frank-Raue K; Raue F; Buhr H J
Prophylactic thyroidectomy in MEN IIA: does the calcitonin level correlate with tumor spread?
Langenbeck's archives of surgery / Deutsche Gesellschaft für Chirurgie 1998;383(2):170-3.
1998: Berndt I; Reuter M; Saller B; Frank-Raue K; Groth P; Grussendorf M; Raue F; Ritter M M; Höppner W
A new hot spot for mutations in the ret protooncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2A.
The Journal of clinical endocrinology and metabolism 1998;83(3):770-4.
1997: Frank-Raue K; Höppner W; Buhr H; Herfarth C; Ziegler R; Raue F
[Mutations of ret-proto-oncogene in thyroid medullary carcinoma]
Deutsche medizinische Wochenschrift (1946) 1997;122(6):143-9.
1997: Senninger N; Colombo-Benkmann M; Haas S; Frank-Raue K; Herfarth C
[Calcium metabolism after thyroidectomy with modified radical neck dissection and parathyroid gland autotransplantation]
Langenbecks Archiv für Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft für Chirurgie. Kongress 1997;114():1161-3.
1997: Frank-Raue K; Höppner W; Buhr H; Herfarth C; Raue F
Results and follow-up in eleven MEN 2A gene carriers after prophylactic thyroidectomy.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 1997;105 Suppl 4():76-8.
1996: Frank-Raue K; Kratt T; Höppner W; Buhr H; Ziegler R; Raue F
Diagnosis and management of pheochromocytomas in patients with multiple endocrine neoplasia type 2-relevance of specific mutations in the RET proto-oncogene.
European journal of endocrinology / European Federation of Endocrine Societies 1996;135(2):222-5.
1996: Frank-Raue K; Höppner W; Frilling A; Kotzerke J; Dralle H; Haase R; Mann K; Seif F; Kirchner R; Rendl J; Deckart H F; Ritter M M; Hampel R; Klempa J; Scholz G H; Raue F
Mutations of the ret protooncogene in German multiple endocrine neoplasia families: relation between genotype and phenotype. German Medullary Thyroid Carcinoma Study Group.
The Journal of clinical endocrinology and metabolism 1996;81(5):1780-3.
1996: Frank-Raue K; Höppner W; Buhr H; Herfarth C; Ziegler R; Raue F
Application of genetic screening in families with hereditary medullary thyroid carcinoma.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 1996;104 Suppl 4():108-10.
1995: Frank-Raue K; Bihl H; Dörr U; Buhr H; Ziegler R; Raue F
Somatostatin receptor imaging in persistent medullary thyroid carcinoma.
Clinical endocrinology 1995;42(1):31-7.
1994: Grauer A; Frank-Raue K; Schroth J; Raue F; Ziegler R
[Neutralizing antibodies against salmon calcitonin. The cause of a treatment failure in Paget's disease]
Deutsche medizinische Wochenschrift (1946) 1994;119(14):507-10.
1994: Raue F; Frank-Raue K; Grauer A
Multiple endocrine neoplasia type 2. Clinical features and screening.
Endocrinology and metabolism clinics of North America 1994;23(1):137-56.
1993: Dörr U; Frank-Raue K; Raue F; Sautter-Bihl M L; Guzman G; Buhr H J; Bihl H
The potential value of somatostatin receptor scintigraphy in medullary thyroid carcinoma.
Nuclear medicine communications 1993;14(6):439-45.
1993: Raue F; Geiger S; Buhr H; Frank-Raue K; Ziegler R
[The prognostic importance of calcitonin screening in familial medullary thyroid carcinoma]
Deutsche medizinische Wochenschrift (1946) 1993;118(3):49-52.
1993: Dörr U; Würstlin S; Frank-Raue K; Raue F; Hehrmann R; Iser G; Scholz M; Guhl L; Buhr H J; Bihl H
Somatostatin receptor scintigraphy and magnetic resonance imaging in recurrent medullary thyroid carcinoma: a comparative study.
Hormone and metabolic research. Supplement series 1993;27():48-55.
1993: Frank-Raue K; Ziegler R; Raue F
The use of octreotide in the treatment of medullary thyroid carcinoma.
Hormone and metabolic research. Supplement series 1993;27():44-7.
1992: Frank-Raue K; Raue F; Buhr H J; Baldauf G; Lorenz D; Ziegler R
Localization of occult persisting medullary thyroid carcinoma before microsurgical reoperation: high sensitivity of selective venous catheterization.
Thyroid : official journal of the American Thyroid Association 1992;2(2):113-7.
1990: Grauer A; Raue F; Schneider H G; Frank-Raue K; Ziegler R
In vitro detection of neutralizing antibodies after treatment of Paget's disease of bone with nasal salmon calcitonin.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1990;5(4):387-91.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Karin Frank-Raue

Research Profile (preview)

Disorders

Chemicals & Drugs

Procedures

Physiology

Living Beings

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Karin Frank-Raue (preview)

All Publications